2020
Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis
Shahanavaz S, Zahn EM, Levi DS, Aboulhousn JA, Hascoet S, Qureshi AM, Porras D, Morgan GJ, Bauser Heaton H, Martin MH, Keeshan B, Asnes JD, Kenny D, Ringewald JM, Zablah JE, Ivy M, Morray BH, Torres AJ, Berman DP, Gillespie MJ, Chaszczewski K, Zampi JD, Walsh KP, Julien P, Goldstein BH, Sathanandam SK, Karsenty C, Balzer DT, McElhinney DB. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis. Journal Of The American College Of Cardiology 2020, 76: 2847-2858. PMID: 33303074, DOI: 10.1016/j.jacc.2020.10.041.Peer-Reviewed Original ResearchConceptsTranscatheter pulmonary valve replacementPulmonary valve replacementSAPIEN XTValve replacementS3 valveMost patientsShort-term outcome dataGreater pulmonary regurgitationMaximum Doppler gradientOutflow tract anatomyTricuspid valve injurySAPIEN 3 valveSerious adverse eventsBalloon-expandable valveShort-term outcomesSurgical valve replacementValve complicationsMulticenter registryUrgent surgeryAdverse eventsDoppler gradientPulmonary regurgitationSAPIEN prosthesisTotal patientsValve injuryOutcomes of Adults with Congenital Heart Disease Supported with Extracorporeal Life Support After Cardiac Surgery.
Dolgner SJ, Keeshan BC, Burke CR, McMullan DM, Chan T. Outcomes of Adults with Congenital Heart Disease Supported with Extracorporeal Life Support After Cardiac Surgery. ASAIO Journal 2020, 66: 1096-1104. PMID: 33136596, DOI: 10.1097/mat.0000000000001141.Peer-Reviewed Original ResearchConceptsExtracorporeal life supportAdult congenital heart diseaseFontan physiologyCardiac surgeryCongenital heart diseaseRisk factorsACHD patientsNeurologic complicationsHeart diseaseExtracorporeal Life Support Organization databaseLife supportMulticenter international registryOutcomes of adultsMultivariate logistic regressionECLS centersECLS useRenal complicationsECLS supportOverall mortalityPulmonary hemorrhageCardiopulmonary supportNeuromuscular blockadeInternational registryECLS cannulationFemale gender
2017
Value of a flow cytometry cross‐match in the setting of a negative complement‐dependent cytotoxicity cross‐match in heart transplant recipients
Keeshan BC, O'Connor MJ, Lin KY, Monos D, Lind C, Mascio CE, Rame JE, Spray TL, Shaddy RE, Rossano JW. Value of a flow cytometry cross‐match in the setting of a negative complement‐dependent cytotoxicity cross‐match in heart transplant recipients. Clinical Transplantation 2017, 31 PMID: 28766759, DOI: 10.1111/ctr.13064.Peer-Reviewed Original ResearchConceptsHeart transplant recipientsGraft survivalPositive FCXMHeart transplantationTransplant recipientsT cellsB cellsNegative complement-dependent cytotoxicityCox proportional hazard modelingDecreased graft survivalOrgan Sharing databaseHLA-specific antibodiesKaplan-Meier analysisCross-match resultsProportional hazard modelingDifferent patient cohortsComplement-dependent cytotoxicityXM patientsGraft failureSharing databaseUnited NetworkPatient cohortInclusion criteriaCross matchClinical relevance
2015
Changes in the methodology of pre‐heart transplant human leukocyte antibody assessment: an analysis of the United Network for Organ Sharing database
O'Connor MJ, Keeshan BC, Lin KY, Monos D, Lind C, Paridon SM, Mascio CE, Shaddy RE, Rossano JW. Changes in the methodology of pre‐heart transplant human leukocyte antibody assessment: an analysis of the United Network for Organ Sharing database. Clinical Transplantation 2015, 29: 842-850. PMID: 26172275, DOI: 10.1111/ctr.12590.Peer-Reviewed Original ResearchConceptsPanel reactive antibodyHuman leukocyte antibodiesOrgan Sharing databaseHeart transplantationReactive antibodiesGraft lossLeukocyte antibodiesSharing databaseUnited NetworkAntibody assessmentFlow cytometryClass IPre-transplant patientsUnderwent heart transplantationTime of transplantationPrimary outcome measureFlow cytometric assessmentGraft survivalMultivariable analysisOutcome measuresTransplantationCytometric assessmentPatientsStudy periodAntibodies